Skip to main content
. 2009 Nov 4;35(2):581–590. doi: 10.1038/npp.2009.164

Figure 1.

Figure 1

(a) Study design. (b) Patient flow diagram. ER, early responder; ENR, early non-responder; ENR–OLZ, early non-responder switched to olanzapine; ENR–RIS, early non-responder maintained on risperidone; mg, milligram; SPI, Study Period I; SPII, Study Period II; SPIII, Study Period III; V, Visit; wk, week.